Read More Healthcare Industry News Island Pharmaceuticals (ASX:ILA) shares rise as Texas Biomed expands Galidesivir regulatory pathway Island Pharmaceuticals adds Texas Biomed to Galidesivir’s FDA Animal Rule program, expanding dose evidence while raising execution and timing stakes now. bySrinathJuly 13, 2026